Osteopore Ltd - Asset Resilience Ratio
Osteopore Ltd (OSX) has an Asset Resilience Ratio of 43.09% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read OSX liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2024)
This chart shows how Osteopore Ltd's Asset Resilience Ratio has changed over time. See OSX net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Osteopore Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see OSX market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$1.77 Million | 42.31% |
| Short-term Investments | AU$32.73K | 0.78% |
| Total Liquid Assets | AU$1.81 Million | 43.09% |
Asset Resilience Insights
- Very High Liquidity: Osteopore Ltd maintains exceptional liquid asset reserves at 43.09% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Osteopore Ltd Industry Peers by Asset Resilience Ratio
Compare Osteopore Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Teleflex Incorporated
NYSE:TFX |
Medical Instruments & Supplies | 4.50% |
|
Touchstone International Medical Science Co Ltd
SHG:688013 |
Medical Instruments & Supplies | 37.86% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Crossject
PA:ALCJ |
Medical Instruments & Supplies | 1.31% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
Annual Asset Resilience Ratio for Osteopore Ltd (2018–2024)
The table below shows the annual Asset Resilience Ratio data for Osteopore Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.18% | AU$5.75K ≈ $4.07K |
AU$3.13 Million ≈ $2.22 Million |
+0.02pp |
| 2023-12-31 | 0.17% | AU$5.56K ≈ $3.93K |
AU$3.34 Million ≈ $2.37 Million |
-0.35pp |
| 2022-12-31 | 0.51% | AU$18.52K ≈ $13.11K |
AU$3.62 Million ≈ $2.56 Million |
-2.85pp |
| 2021-12-31 | 3.36% | AU$201.62K ≈ $142.66K |
AU$6.01 Million ≈ $4.25 Million |
+3.20pp |
| 2020-12-31 | 0.16% | AU$16.40K ≈ $11.60K |
AU$10.25 Million ≈ $7.25 Million |
-0.21pp |
| 2019-12-31 | 0.37% | AU$15.79K ≈ $11.17K |
AU$4.28 Million ≈ $3.03 Million |
+0.18pp |
| 2018-12-31 | 0.18% | AU$9.94K ≈ $7.03K |
AU$5.40 Million ≈ $3.82 Million |
-- |
About Osteopore Ltd
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates spe… Read more